Luigi Mangione due to appear in court again after secret hearing in CEO murder case – UK Times

Alleged CEO assassin Luigi Mangione is set to appear at a state court hearing Tuesday ahead of his highly anticipated murder trial.

Mangione, 28, is accused of fatally shooting UnitedHealthcare CEO Brian Thompson outside a hotel in Midtown Manhattan in December 2024. The brazen killing was widely condemned by public officials but became emblematic of Americans’ frustration with rising healthcare costs and health insurance industry practices.

Mangione has pleaded not guilty to state murder, weapons and forgery charges brought by Manhattan District Attorney Alvin Bragg. His trial is set for September before Justice Gregory Carro in Manhattan.

The agenda for Tuesday’s hearing was not clear and comes two weeks after Carro held a sealed, virtual proceeding with prosecutors and defense lawyers.

Thompson led UnitedHealth Group’s insurance unit before he was shot dead in the early morning outside a hotel where he was staying for an investor conference.

Graphic footage of the killing and a five-day manhunt for a suspect made the case a media fixture and social media sensation. Police found “delay,” “deny” and “depose” written on the ammunition, mimicking a phrase used to describe how insurers avoid paying claims.

Mangione, an Ivy League graduate from a wealthy Maryland family, was arrested five days after the murder, at a McDonald’s in Altoona, Pennsylvania, about 230 miles (about 370 kilometers) west of Manhattan.

He separately pleaded not guilty in April 2025 to murder, weapons and stalking charges brought by Manhattan federal prosecutors.

U.S. District Judge Margaret Garnett, who is overseeing the case, threw out the murder and weapons charges over legal technicalities in a surprise ruling in January. That decision eliminated the possibility that Mangione would face the death penalty, though he still faces a possible sentence of life without parole if convicted of stalking.

Jury selection in that case is set to begin in September, and opening statements in the trial are scheduled for November.